AbCellera focuses on the discovery and development process of antibody drugs, the largest and fastest growing class of successful biologic therapeutics.First Check: Series A | March 2020

Alloy Therapeutics is empowering the global scientific community by being a cheaper and easier way for scientists to build their biotech company on the Alloy platform.First Check: Series B | May 2020

AtaiBeckley is on a mission to transform patient outcomes by developing effective, rapid-acting and convenient mental health treatments.First Check: Series C | October 2020

Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.First Check: Series B | July 2021

General Fusion is advancing practical fusion energy with Magnetized Target Fusion technology to help deliver clean, reliable power for the world.First Check: Series E | May 2021

Peptilogics is a next-generation computational drug discovery and development company for the peptide drug class.First Check: Seed | June 2019

Standard Bots is America's largest AI-native industrial robot manufacturer.First Check: Series A | January 2024

TERN connects top healthcare professionals from India and beyond to global opportunities in the UK, Germany, Saudi Arabia, and more.First Check: Seed | September 2023